StonvexLoading…
StonvexCore line items from RBRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-04 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $373.61M | $1.32B | $938.51M | $588.34M | $278.48M |
Operating Income | Not available | $-345.42M | $-263.04M | $-187.55M | $-93.09M |
Net Income | Not available | $-348.83M | $-261.86M | $-198.03M | $-102.10M |
EPS (Diluted) | $-0.03 | $-1.78 | $-1.34 | $-1.02 | $-0.53 |
Total Assets | Not available | $2.77B | $2.55B | $2.39B | $1.47B |
Total Liabilities | Not available | $3.29B | $3.07B | $2.95B | $2.03B |
Cash & Equivalents | Not available | $380.20M | $307.10M | $322.70M | $284.00M |
Free Cash Flow OCF − CapEx | Not available | $253.28M | $178.78M | $98.03M | $36.80M |
Shares Outstanding | Not available | 196.47M | 195.00M | 193.28M | 191.63M |